Facile Therapeutics

Facile Therapeutics is a biotechnology company that develops therapeutic drugs for clostridium difficile infection.

Business Model:

Revenue: $0

Employees: 1-10

Rankings

Detailed Facile Therapeutics Information

Geographic Data

Facile Therapeutics headquarters map

Address:

City: Belmont

State: California

Zip:

Country: United States

Financial Info

Stage:

grant

Raised Last:

$1M

Raised Total:

$1M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Facile Therapeutics is a biotechnology company that develops therapeutic drugs for clostridium difficile infection. The company demonstrated Ebselen, an anti-toxin that doesn&s;t cause the death of healthy gut bacteria that makes the colon resistant to C diff reinfection. Facile Therapeutics was founded in 2017 by Marc Navre and Matthew Bogyo and is based in Belmont, California.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2019 Non Equity Assistance 1 - SkyDeck Berkeley
SkyDeck Berkeley
2/2020 Grant 1 $1.3M CARB-X
CARB-X
9/2019 Non Equity Assistance 1 - SkyDeck Berkeley
SkyDeck Berkeley
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research